Elevated A-to-I RNA editing in COVID-19 infected individuals.
| Title: | Elevated A-to-I RNA editing in COVID-19 infected individuals. |
|---|---|
| Authors: | Merdler-Rabinowicz R; Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel.; Cancer Data Science Lab, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; The Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Israel.; Gorelik D; Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel.; The Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Israel.; Park J; Department of Physiology, Biophysics and Systems Biology, Weill Cornell Medicine, New York, NY, USA.; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.; Meydan C; Department of Physiology, Biophysics and Systems Biology, Weill Cornell Medicine, New York, NY, USA.; Foox J; Department of Physiology, Biophysics and Systems Biology, Weill Cornell Medicine, New York, NY, USA.; Karmon M; Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel.; The Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Israel.; Roth HS; Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel.; The Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Israel.; Cohen-Fultheim R; Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel.; The Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Israel.; Shohat-Ophir G; Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel.; Leslie and Susan Gonda Multidisciplinary Brain Research Center and The Nanotechnology Institute, Bar-Ilan University, Ramat Gan, Israel.; Eisenberg E; Raymond and Beverly Sackler School of Physics and Astronomy, Tel-Aviv University, Tel Aviv, Israel.; Ruppin E; Cancer Data Science Lab, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Mason CE; Department of Physiology, Biophysics and Systems Biology, Weill Cornell Medicine, New York, NY, USA.; The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; The WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, NY, USA.; Levanon EY; Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel.; The Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Israel. |
| Source: | NAR genomics and bioinformatics [NAR Genom Bioinform] 2023 Oct 18; Vol. 5 (4), pp. lqad092. Date of Electronic Publication: 2023 Oct 18 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101756213 Publication Model: eCollection Cited Medium: Internet ISSN: 2631-9268 (Electronic) Linking ISSN: 26319268 NLM ISO Abbreviation: NAR Genom Bioinform Subsets: PubMed not MEDLINE |
| Imprint Name(s): | Original Publication: [Oxford] : Oxford University Press, [2019]- |
| Abstract: | Given the current status of coronavirus disease 2019 (COVID-19) as a global pandemic, it is of high priority to gain a deeper understanding of the disease's development and how the virus impacts its host. Adenosine (A)-to-Inosine (I) RNA editing is a post-transcriptional modification, catalyzed by the ADAR family of enzymes, that can be considered part of the inherent cellular defense mechanism as it affects the innate immune response in a complex manner. It was previously reported that various viruses could interact with the host's ADAR enzymes, resulting in epigenetic changes both to the virus and the host. Here, we analyze RNA-seq of nasopharyngeal swab specimens as well as whole-blood samples of COVID-19 infected individuals and show a significant elevation in the global RNA editing activity in COVID-19 compared to healthy controls. We also detect specific coding sites that exhibit higher editing activity. We further show that the increment in editing activity during the disease is temporary and returns to baseline shortly after the symptomatic period. These significant epigenetic changes may contribute to the immune system response and affect adverse outcomes seen in post-viral cases.; (© The Author(s) 2023. Published by Oxford University Press on behalf of NAR Genomics and Bioinformatics.) |
| References: | Nat Med. 2016 Oct;22(10):1140-1150. (PMID: 27595325); Bioessays. 2019 Jun;41(6):e1800239. (PMID: 31106880); Biochem Biophys Res Commun. 2021 Jan 29;538:35-39. (PMID: 33234239); Science. 2007 Feb 23;315(5815):1137-40. (PMID: 17322061); Nat Rev Immunol. 2015 Feb;15(2):87-103. (PMID: 25614319); Curr Issues Mol Biol. 2015;17:37-51. (PMID: 25502818); Cell Rep. 2021 Oct 5;37(1):109773. (PMID: 34587479); Annu Rev Virol. 2021 Sep 29;8(1):239-264. (PMID: 33882257); J Biol Chem. 2023 Aug;299(8):104960. (PMID: 37364688); Nucleic Acids Res. 2018 Jan 9;46(1):71-82. (PMID: 29165639); Sci Rep. 2018 Oct 1;8(1):14846. (PMID: 30275491); J Biol Chem. 2004 Feb 6;279(6):4894-902. (PMID: 14615479); J Biol Chem. 2004 Feb 6;279(6):4952-61. (PMID: 14613934); Genome Biol. 2007;8(2):R29. (PMID: 17326827); iScience. 2021 Jul 23;24(7):102711. (PMID: 34127958); Front Immunol. 2020 Jun 16;11:1446. (PMID: 32612617); Nat Biotechnol. 2004 Aug;22(8):1001-5. (PMID: 15258596); Cell Rep. 2014 Nov 20;9(4):1482-94. (PMID: 25456137); PLoS Biol. 2004 Dec;2(12):e391. (PMID: 15534692); Curr Res Immunol. 2021;2:52-59. (PMID: 33969287); Genome Res. 2004 Sep;14(9):1719-25. (PMID: 15342557); Elife. 2021 Mar 16;10:. (PMID: 33724185); J Invest Dermatol. 2023 Jun;143(6):933-943.e8. (PMID: 36502941); Nat Methods. 2019 Nov;16(11):1131-1138. (PMID: 31636457); Immunity. 2015 Nov 17;43(5):933-44. (PMID: 26588779); Front Immunol. 2013 Dec 04;4:429. (PMID: 24409178); Nat Commun. 2021 Mar 12;12(1):1660. (PMID: 33712587); N Engl J Med. 2020 Dec 17;383(25):2451-2460. (PMID: 32412710); Sci Rep. 2018 Apr 11;8(1):5793. (PMID: 29643425); Front Genet. 2021 Jul 23;12:686851. (PMID: 34367244); Mol Cell Biol. 1995 Oct;15(10):5376-88. (PMID: 7565688); Nature. 2017 Oct 11;550(7675):249-254. (PMID: 29022589); Genome Biol. 2011 Dec 28;12(12):236. (PMID: 22204421); Genome Res. 2014 Mar;24(3):365-76. (PMID: 24347612); Bioinformatics. 2013 Jul 15;29(14):1813-4. (PMID: 23742983); Bioinformatics. 2013 Jan 1;29(1):15-21. (PMID: 23104886); Curr Opin Immunol. 2013 Feb;25(1):103-8. (PMID: 23246037); BMC Bioinformatics. 2010 Jun 23;11:341. (PMID: 20573248); Cell Rep. 2021 Aug 17;36(7):109527. (PMID: 34348131); Science. 2015 Sep 4;349(6252):1115-20. (PMID: 26275108); Clin Transl Med. 2021 Sep;11(9):e534. (PMID: 34586723); Proc Natl Acad Sci U S A. 2022 Mar 15;119(11):. (PMID: 35217532); J Cell Biol. 2018 Oct 1;217(10):3545-3559. (PMID: 30006461); Lancet Neurol. 2020 Sep;19(9):767-783. (PMID: 32622375); Virology. 1995 Jul 10;210(2):508-11. (PMID: 7618288); Nat Commun. 2022 Mar 4;13(1):1184. (PMID: 35246538); Nat Methods. 2017 Apr;14(4):417-419. (PMID: 28263959); J Immunol. 2021 Apr 15;206(8):1691-1696. (PMID: 33782089); Nat Rev Immunol. 2015 Jul;15(7):429-40. (PMID: 26052098); Cell Rep. 2021 Jan 12;34(2):108628. (PMID: 33440148); Nucleic Acids Res. 2014 Jun;42(11):6876-84. (PMID: 24829451); Science. 2020 Aug 7;369(6504):718-724. (PMID: 32661059); Sci Adv. 2020 Jun 17;6(25):eabb5813. (PMID: 32596474); Nucleic Acids Res. 2017 Jan 4;45(D1):D750-D757. (PMID: 27587585); Viruses. 2022 Apr 13;14(4):. (PMID: 35458534); Annu Rev Microbiol. 2001;55:255-81. (PMID: 11544356); Cell Syst. 2021 Jan 20;12(1):23-40.e7. (PMID: 33096026) |
| Grant Information: | R01 AI125416 United States AI NIAID NIH HHS; R21 EB031466 United States EB NIBIB NIH HHS; R01 AI151059 United States AI NIAID NIH HHS; R21 AI129851 United States AI NIAID NIH HHS; U01 DA053941 United States DA NIDA NIH HHS; R01 MH117406 United States MH NIMH NIH HHS |
| Molecular Sequence: | figshare 10.6084/m9.figshare.24164169.v1 |
| Entry Date(s): | Date Created: 20231020 Latest Revision: 20250830 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC10583280 |
| DOI: | 10.1093/nargab/lqad092 |
| PMID: | 37859800 |
| Database: | MEDLINE |
Journal Article